ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1048
0,00%
Bitcoin
70.970,63
-0,67%
Brent Oil
82,785
-0,89%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Bellerophon Therapeutics Inc (BLPH)

  7. Bellerophon Therapeutics Inc (BLPH) Notícias

BLPH

Bellerophon Therapeutics (BLPH)

Bellerophon Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BLPH
DataHoraFonteTítuloCódigoCompanhia
30/01/202411:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202416:31Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202412:46Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
03/01/202415:49Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BLPHBellerophon Therapeutics Inc
27/10/202311:50Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202321:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202314:59Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202314:59Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
14/08/202317:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLPHBellerophon Therapeutics Inc
29/06/202317:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLPHBellerophon Therapeutics Inc
12/06/202307:45Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLPHBellerophon Therapeutics Inc
09/06/202317:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
08/06/202307:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BLPHBellerophon Therapeutics Inc
07/06/202318:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BLPHBellerophon Therapeutics Inc
02/06/202309:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BLPHBellerophon Therapeutics Inc
26/05/202317:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BLPHBellerophon Therapeutics Inc
25/05/202312:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BLPHBellerophon Therapeutics Inc
15/05/202317:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLPHBellerophon Therapeutics Inc
28/04/202309:39Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BLPHBellerophon Therapeutics Inc
28/04/202309:34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BLPHBellerophon Therapeutics Inc
03/04/202318:47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BLPHBellerophon Therapeutics Inc
31/03/202309:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLPHBellerophon Therapeutics Inc
06/03/202318:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BLPHBellerophon Therapeutics Inc
15/11/202210:45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Bellerophon (BLPH)NASDAQ:BLPHBellerophon Therapeutics Inc
27/09/202213:25TipRanksBLPH (NASDAQ:BLPH) Soars on FDA Nod to Lung Study Change; Street Sees 24x GainsNASDAQ:BLPHBellerophon Therapeutics Inc
12/05/202207:27TipRanksH.C. Wainwright Thinks Bellerophon’s Stock is Going to RecoverNASDAQ:BLPHBellerophon Therapeutics Inc
25/04/202209:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BLPHBellerophon Therapeutics Inc
06/04/202208:40TipRanksBrookline Capital Markets Thinks Bellerophon’s Stock is Going to RecoverNASDAQ:BLPHBellerophon Therapeutics Inc
04/01/202218:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BLPHBellerophon Therapeutics Inc
22/12/202119:15TipRanksBellerophon Stock Has Massive Upside Potential, Says AnalystNASDAQ:BLPHBellerophon Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BLPH

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
LUPA3
LUPATECH ON
BOV
CASH3
Meliuz S.A ON
BOV
INBR32
Inter &
BOV
GOLL4
GOL PN
BOV
LWSA3
LOCAWEB ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados